NCT04177641View on ClinicalTrials.gov

Evaluation of Thioldisulfide Balance in Cervical Preinvasive Lesions

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 10, 2020

Conditions
Oxidative StressLow Grade Squamous Intraepithelial LesionHigh-Grade Squamous Intraepithelial Lesions
Interventions
DIAGNOSTIC_TEST

Disulphide(μmol/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

DIAGNOSTIC_TEST

Total Oxidant Capacity(μmolH2O2Equiv/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

Trial Locations (1)

48000

Mugla Sıtkı Kocman University Faculty of Medicine, Muğla

All Listed Sponsors
lead

Muğla Sıtkı Koçman University

OTHER

NCT04177641 - Evaluation of Thioldisulfide Balance in Cervical Preinvasive Lesions | Biotech Hunter | Biotech Hunter